Сделай Сам Свою Работу на 5

Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V, Rodriguez-Wolf M, et al.

Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?

Exp Neurol 2001;167(1):40-47

 

Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, et al.

Interleukin-10 in the brain.

Crit Rev Immunol 2001;21(5):427-49

 

Stumm R, Culmsee C, Schafer MK, Krieglstein J, Weihe E.

Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebro-cortical circuits and cerebrovenular endothelium.

J Neurosci 2001;21(3):798-811

 

Stvolinsky S, Kuklev M, Dobrota D, Mezesova V, Boldyrev A.

Carnosine protects rats under global ischemia. Brain Res Bull 2000;53(4):445-448

 

Szutowicz A.

Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons. J Neurosci Res 2001;66(5):1009-1018

 

Talesa VN.

Acetylcholinesterase in Alzheimer's disease. Mech Agei Dev 2001;122(16):1961-9

 

Tanaka H, Katoh A, Oguro K, Shimazaki K, Gomi H, Itohara S, Masuzawa T.

Disturbance of hippocampal long-term potentiation after transient ischemia in GFAP deficient mice. J Neurosci Res 2002;67(1):11-20

 

Tanaka K.

Alteration of second messengers during acute cerebral ischemia – adenylate-cyclase, cyclic AMP- dependent protein kinase, and cyclic AMP response element binding protein.

Prog Neurobiol 2001;65(2):173-207

 

Tanaka K, Nogawa S, Ito D, Suzuki S, Dembo T, Kosakai A, Fukuuchi Y.

Activated phosphorylation of cyclic AMP response element binding protein is associated with preservation of striatal neurons after focal cerebral ischemia in the rat.

Neuroscience 2000;100(2):345-354


Tanaka K, Nogawa S, Nagata E, Suzuki S, Dembo T, Kosakai A, Fukuuchi Y.

Effects of blockade of voltage-sensitive Ca(2+)/Na(+) channels by a novel phenyl-pyrimidine derivative, NS-7, on CREB phosphorylation in focal cerebral ischemia in the rat.

Brain Res 2000;873(1):83-93

 

Tang Y, Yamada K, Kanou Y, Miyazaki T, Xiong X, Kambe F, Murata Y, Seo H, et al.Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of ß-amyloid in rats.

Brain Res Mol Brain Res 2000;80(2):188-197

 

Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P.

Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 2002;23(2):237-243

 

Tarkowski E, Ringqvist A, Blennow K, Wallin A, Wennmalm A.

Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 2000;11(6):322-326

 

Thorns V, Licastro F, Masliah E.

Locally reduced levels of acidic FGF lead to decreased expression of 28-kda calbindin and contribute to the selective vulnerability of the neurons in the entorhinal cortex in Alzheimer's disease.

Neuropathology 2001;21(3):203-211

 

Togashi H, Mori K, Itoh Y, Matsumoto M, Ueno K, Ohashi S, Otani H, Yoshioka M.

Involvement of interleukin-1beta/nitric oxide pathway in the postischemic impairment of long-term potentiation of the rat hippocampus. Neurosci Lett 2001;313(3):133-36

 

Toliver-Kinsky T, Wood T, Perez-Polo JR.

Nuclear factor kappaB/p49 is a negative regulatory factor in nerve growth factor-induced choline acetyltransferase promoter activity in PC12 cells.

J Neurochem 2000;75(6):2241-2251



 

De la Torre JC, Stefano GB.

Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev 2000;34(3):119-136

 

Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N.

Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 2002;22(1):38-43

 

Tsuzuki N, Miyazawa T, Matsumoto K, Nakamura T, Shima K.

Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats. Neurol Res 2001;23(4):417-424

 

Ueno T, Sawa Y, Kitagawa-Sakakida S, Nishimura M, Morishita R, Kaneda Y.еа.

Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest.

J Thorac Cardiovasc Surg 2001;122(4):720-727

 

Urakami K, Wakutani Y, Wada-Isoe K, Yamagata K, Adachi Y, Nakashima K.

[Causative genes in Alzheimer's disease]

Nippon Ronen Igakkai Zasshi 2001;38(2):117-120

 

Valenti G.

Neuropeptide changes in dementia: pathogenetic implications and diagnostic. Gerontology 1996; 42(5):241-256


Violante V, Luongo A, Pepe I, Annunziata S, Gentile V.

Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.

Brain Res Bull 2001;56(3-4):169-172

 

Walther T, Olah L, Harms C, Maul B, Bader M, et al.

Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 2002;16(2):169-176

 

Wang H, Xu L, Venkatachalam S, Trzaskos JM, Friedman SM, et al.

Differential regulation of IL-1beta and TNF-alpha RNA expression by MEK1 inhibitor after focal cerebral ischemia in mice.

BBRC 2001;286(5):869-874

 

Wang JM, Hayashi T, Zhang WR, Li F, Iwai M, Abe K.

Reduction of ischemic damage by application of insulin-like growth factor-1 in rat brain after transient ischemia. Acta Med Okayama 2001;55(1):25-30

 

Wang X, Shimizu-Sasamata M, Moskowitz MA, Newcomb R, Lo EH.

Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice. Neurosci Lett 2001;313(3):121-124

 

White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman L, et al.

Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 2000;179(S 1-2):1-33

 

Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M.Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001;21(7):857-864

 

Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M, Rosewell KL.

Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies.

Brain Res Brain Res Rev 2001;37(1-3):313-319

 

Woulfe JM, Hammond R, Richardson B, Sooriabalan D, Parks W, Rippstein P, et al.Reduction of neuronal intranuclear rodlets immunoreactive for tubulin and glucocorticoid receptor in Alzheimer's disease. Brain Pathol 2002;12(3):300-307

 

Wyss-Coray T, Lin C, von Euw D, Masliah E, Mucke L, Lacombe P.

Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.

Ann N Y Acad Sci 2000;903:317-323

 

Yamashita K, Kataoka Y, Sakurai-Yamashita Y, Shigematsu K, Himeno A, et al.

Involvement of glial endothelin/nitric oxide in delayed neuronal death of rat hippocampus after transient forebrain ischemia. Cell Mol Neurobiol 2000;20(5):541-551

 

Yang JT, Chang CN, Lee TH, Lin TN, Hsu JC, Hsu YH, Wu JH.

Hyperbaric oxygen treatment decreases post-ischemic neurotrophin-3 mRNA down-regulation in the rat hippocampus. Neuroreport 2001;12(16):3589-3592

 

Yang SH, He Z, Wu SS, He YJ, Cutright J, Millard WJ, Day AL, Simpkins JW.

17- beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage. J Cereb Blood Flow Metab 2001;21(2):174-181

 

Yoshiyama Y, Arai K, Hattori T.

Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease. Neuroreport 2001;12(12):2641-2645


Yu X, Li SH, Nguyen HP, Li XJ.

Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum Mol Genet 2002;11(8):905-914

 

Yu X, Shacka JJ, Eells JB, Suarez-Quian C, et al.

Erythropoietin receptor signalling is required for normal brain development. Development 2002;129(2):505-516

 

Zhang Y, Pardridge WM.

Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain- derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.

Stroke 2001;32(6):1378-1384

 

Zhang Z, Chopp M.

Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 2002;12(2):62-66

 

Zhao LR, Risedal A, Wojcik A, Hejzlar J, Johansson BB, Kokaia Z.

Enriched environment influences brain-derived neurotrophic factor levels in rat forebrain after focal stroke. Neurosci Lett 2001;305(3):169-172

 

Zheng WH, Kar S, Dore S, Quirion R.

Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway. J Neural Transm Suppl 2000;(60):261-272

 

Zhu Y, Culmsee C, Roth-Eichhorn S, Krieglstein J.

Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta- binding protein-1 and transforming growth factor-beta1 expression in rat hippo-campus after transient forebrain ischemia. Neuroscience 2001;107(4):593-602

 

====================


Р А З Д Е Л V.

 

ЦЕРЕБРОЛИЗИН®.



©2015- 2019 stydopedia.ru Все материалы защищены законодательством РФ.